Copyright © 2011 Valerie C. Anderson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. A. J. Bastos Leite, P. Scheltens, and F. Barkhof, “Pathological aging of the brain: an overview,” Topics in Magnetic Resonance Imaging, vol. 15, no. 6, pp. 369–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
2. B. V. Zlokovic, “Neurovascular mechanisms of Alzheimer's neurodegeneration,” Trends in Neurosciences, vol. 28, no. 4, pp. 202–208, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. C. Iadecola and P. B. Gorelick, “Converging pathogenic mechanisms in vascular and neurodegenerative dementia,” Stroke, vol. 34, no. 2, pp. 335–337, 2003. View at Publisher · View at Google Scholar · View at Scopus
4. A. S. Lossinsky and R. R. Shivers, “Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review,” Histology and Histopathology, vol. 19, no. 2, pp. 535–564, 2004. View at Scopus
5. P. Ballabh, A. Braun, and M. Nedergaard, “The blood-brain barrier: an overview: structure, regulation, and clinical implications,” Neurobiology of Disease, vol. 16, no. 1, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. N. J. Abbott, “Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology,” Neurochemistry International, vol. 45, no. 4, pp. 545–552, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. E. A. Neuwelt, N. H. Greig, C. Raffel et al., “Mechanisms of disease: the blood-brain barrier,” Neurosurgery, vol. 54, no. 1, pp. 131–142, 2004. View at Scopus
8. S. W. Lee, W. J. Kim, Y. K. Choi et al., “SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier,” Nature Medicine, vol. 9, no. 7, pp. 900–906, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. N. J. Abbott, L. Rönnbäck, and E. Hansson, “Astrocyte-endothelial interactions at the blood-brain barrier,” Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41–53, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. D. R. Thal, E. Ghebremedhin, M. Orantes, and O. D. Wiestler, “Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 12, pp. 1287–1301, 2003. View at Scopus
11. L. Buée, P. R. Hof, and A. Delacourte, “Brain microvascular changes in Alzheimer's disease and other dementias,” Annals of the New York Academy of Sciences, vol. 826, pp. 7–24, 1997. View at Publisher · View at Google Scholar · View at Scopus
12. E. Farkas and P. G. M. Luiten, “Cerebral microvascular pathology in aging and Alzheimer's disease,” Progress in Neurobiology, vol. 64, no. 6, pp. 575–611, 2001. View at Publisher · View at Google Scholar · View at Scopus
13. P. A. Stewart, K. Hayakawa, M. A. Akers, and H. V. Vinters, “A morphometric study of the blood-brain barrier in Alzheimer's disease,” Laboratory Investigation, vol. 67, no. 6, pp. 734–742, 1992. View at Scopus
14. L. Claudio, “Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients,” Acta Neuropathologica, vol. 91, no. 1, pp. 6–14, 1996. View at Publisher · View at Google Scholar · View at Scopus
15. E. Farkas, G. I. De Jong, E. Apró, R. A. I. De Vos, E. N. H. Jansen Steur, and P. G. M. Luiten, “Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension: What is the functional link?” Annals of the New York Academy of Sciences, vol. 903, pp. 72–82, 2000. View at Scopus
16. T. M. Berzin, B. D. Zipser, M. S. Rafii et al., “Agrin and microvascular damage in Alzheimer's disease,” Neurobiology of Aging, vol. 21, no. 2, pp. 349–355, 2000. View at Publisher · View at Google Scholar · View at Scopus
17. M. O. Romanitan, B. O. Popescu, B. Winblad, O. A. Bajenaru, and N. Bogdanovic, “Occludin is overexpressed in Alzheimer's disease and vascular dementia,” Journal of Cellular and Molecular Medicine, vol. 11, no. 3, pp. 569–579, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. M. O. Romanitan, B. O. Popescu, T. Spulber et al., “Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains,” Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1088–1100, 2010. View at Publisher · View at Google Scholar · View at PubMed
19. C. Haass and D. J. Selkoe, “Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide,” Nature Reviews Molecular Cell Biology, vol. 8, no. 2, pp. 101–112, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. M. M. Verbeel, R. M. W. de Waal, and H. V. Vinters, Cerebral Amyloid Angiopathy in Alzheimer's Disease and Related Disorders, Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000.
21. D. R. Thal, W. S. T. Griffin, R. A. I. de Vos, and E. Ghebremedhin, “Cerebral amyloid angiopathy and its relationship to Alzheimer's disease,” Acta Neuropathologica, vol. 115, no. 6, pp. 599–609, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. J. Attems and K. A. Jellinger, “Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study,” Acta Neuropathologica, vol. 107, no. 2, pp. 83–90, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. H. Yamaguchi, T. Yamazaki, C. A. Lemere, M. P. Frosch, and D. J. Selkoe, “Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: an immunoelectron microscopic study,” American Journal of Pathology, vol. 141, no. 1, pp. 249–259, 1992. View at Scopus
24. D. R. Thal, E. Capetillo-Zarate, S. Larionov, M. Staufenbiel, S. Zurbruegg, and N. Beckmann, “Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances,” Neurobiology of Aging, vol. 30, no. 12, pp. 1936–1948, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. A. E. Roher, J. D. Lowenson, S. Clarke et al., “β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 22, pp. 10836–10840, 1993. View at Publisher · View at Google Scholar · View at Scopus
26. R. D. Bell and B. V. Zlokovic, “Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease,” Acta Neuropathologica, vol. 118, no. 1, pp. 103–113, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. R. O. Carare, M. Bernardes-Silva, T. A. Newman et al., “Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology,” Neuropathology and Applied Neurobiology, vol. 34, no. 2, pp. 131–144, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. S. Marco and S. D. Skaper, “Amyloid β-peptide alters tight junction protein distribution and expression in brain microvessel endothelial cells,” Neuroscience Letters, vol. 401, no. 3, pp. 219–224, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. K. M. Cullen, Z. Kócsi, and J. Stone, “Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages,” Neurobiology of Aging, vol. 27, no. 12, pp. 1786–1796, 2006. View at Publisher · View at Google Scholar · View at Scopus
30. C. A. Hawkes, W. Härtig, J. Kacza et al., “Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy,” Acta Neuropathologica, vol. 121, no. 4, pp. 431–443, 2011. View at Publisher · View at Google Scholar · View at PubMed
31. S. D. Preston, P. V. Steart, A. Wilkinson, J. A. R. Nicoll, and R. O. Weller, “Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain,” Neuropathology and Applied Neurobiology, vol. 29, no. 2, pp. 106–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
32. A. T. Argaw, B. T. Gurfein, Y. Zhang, A. Zameer, and G. R. John, “VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1977–1982, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. R. Pluta, S. Januszewski, and M. Uamek, “White matter, brain edema, blood brain barrier,” Journal of Cerebral Blood Flow & Metabolism, vol. 25, p. S251, 2005.
34. A. T. Argaw, B. T. Gurfein, Y. Zhang, A. Zameer, and G. R. John, “VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1977–1982, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. I. Mateo, J. Llorca, J. Infante et al., “Low serum VEGF levels are associated with Alzheimer's disease,” Acta Neurologica Scandinavica, vol. 116, no. 1, pp. 56–58, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. L. Thirumangalakudi, P. G. Samany, A. Owoso, B. Wiskar, and P. Grammas, “Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 10, no. 1, pp. 111–118, 2006. View at Scopus
37. M. Chiappelli, B. Borroni, S. Archetti et al., “VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment,” Rejuvenation Research, vol. 9, no. 4, pp. 485–493, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. D. Paris, N. Patel, A. Delledonne, A. Quadros, R. Smeed, and M. Mullan, “Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis,” Neuroscience Letters, vol. 366, no. 1, pp. 80–85, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. K. A. Jellinger, “Alzheimer disease and cerebrovascular pathology: an update,” Journal of Neural Transmission, vol. 109, no. 5-6, pp. 813–836, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. G. J. Harris, R. F. Lewis, A. Satlin et al., “Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease,” American Journal of Psychiatry, vol. 153, no. 5, pp. 721–724, 1996. View at Scopus
41. K. A. Johnson and M. S. Albert, “Perfusion abnormalities in prodromal AD,” Neurobiology of Aging, vol. 21, no. 2, pp. 289–292, 2000. View at Publisher · View at Google Scholar · View at Scopus
42. A. Bozzao, R. Floris, M. E. Baviera, A. Apruzzese, and G. Simonetti, “Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load,” American Journal of Neuroradiology, vol. 22, no. 6, pp. 1030–1036, 2001.
43. S. S. Jung, W. Zhang, and W. E. Van Nostrand, “Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells,” Journal of Neurochemistry, vol. 85, no. 5, pp. 1208–1215, 2003. View at Publisher · View at Google Scholar · View at Scopus
44. M. J. Tait, S. Saadoun, B. A. Bell, and M. C. Papadopoulos, “Water movements in the brain: role of aquaporins,” Trends in Neurosciences, vol. 31, no. 1, pp. 37–43, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
45. Z. Zador, O. Bloch, X. Yao, and G. T. Manley, “Aquaporins: role in cerebral edema and brain water balance,” Progress in Brain Research, vol. 161, pp. 185–194, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
46. P. Agre, S. Nielsen, and O. P. Ottersen, “Towards a molecular understanding of water homeostasis in the brain,” Neuroscience, vol. 129, no. 4, pp. 849–850, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. P. Agre, “The aquaporin water channels,” Proceedings of the American Thoracic Society, vol. 3, no. 1, pp. 5–13, 2006. View at Publisher · View at Google Scholar · View at PubMed
48. M. Amiry-Moghaddam and O. P. Ottersen, “The molecular basis of water transport in the brain,” Nature Reviews Neuroscience, vol. 4, no. 12, pp. 991–1001, 2003. View at Scopus
49. T. Pannicke, A. Wurm, I. Iandiev et al., “Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress,” Journal of Neuroscience Research, vol. 88, no. 13, pp. 2877–2888, 2010. View at Publisher · View at Google Scholar · View at PubMed
50. E. E. Benarroch, “Aquaporin-4, homeostasis, and neurologic disease,” Neurology, vol. 69, no. 24, pp. 2266–2268, 2007. View at Publisher · View at Google Scholar · View at PubMed
51. T. Eid, T. S. W. Lee, M. J. Thomas et al., “Loss of perivascular aquaporin 4 may underlie deficient water and K homeostasis in the human epileptogenic hippocampus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 4, pp. 1193–1198, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
52. S. Nag, J. L. Manias, and D. J. Stewart, “Pathology and new players in the pathogenesis of brain edema,” Acta Neuropathologica, vol. 118, no. 2, pp. 197–217, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. S. Saadoun, M. J. Tait, A. Reza et al., “AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology,” Neuroscience, vol. 161, no. 3, pp. 764–772, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
54. J. Zhou, H. Kong, X. Hua, M. Xiao, J. Ding, and G. Hu, “Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice,” NeuroReport, vol. 19, no. 1, pp. 1–5, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. D. M. Wilcock, M. P. Vitek, and C. A. Colton, “Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease,” Neuroscience, vol. 159, no. 3, pp. 1055–1069, 2009. View at Publisher · View at Google Scholar · View at PubMed
56. P. A. Stewart, “Endothelial vesicles in the blood-brain barrier: are they related to permeability?” Cellular and Molecular Neurobiology, vol. 20, no. 2, pp. 149–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
57. M. Ujiie, D. L. Dickstein, D. A. Carlow, and W. A. Jefferies, “Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model,” Microcirculation, vol. 10, no. 6, pp. 463–470, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. J. F. Poduslo, G. L. Curran, T. M. Wengenack, B. Malester, and K. Duff, “Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease,” Neurobiology of Disease, vol. 8, no. 4, pp. 555–567, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
59. I. Skoog, A. Wallin, P. Fredman et al., “A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia,” Neurology, vol. 50, no. 4, pp. 966–971, 1998. View at Scopus
60. A. Algotsson and B. Winblad, “The integrity of the blood-brain barrier in Alzheimer's disease,” Acta Neurologica Scandinavica, vol. 115, no. 6, pp. 403–408, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. G. L. Bowman, J. A. Kaye, M. Moore, D. Waichunas, N. E. Carlson, and J. F. Quinn, “Blood-brain barrier impairment in Alzheimer disease: stability and functional significance,” Neurology, vol. 68, no. 21, pp. 1809–1814, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. G. J. Harris, R. F. Lewis, A. Satlin et al., “Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine,” American Journal of Neuroradiology, vol. 19, no. 9, pp. 1727–1732, 1998. View at Scopus
63. L. C. Maas, G. J. Harris, A. Satlin, C. D. English, R. F. Lewis, and P. F. Renshaw, “Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis,” Journal of Magnetic Resonance Imaging, vol. 7, no. 1, pp. 215–219, 1997. View at Publisher · View at Google Scholar · View at Scopus
64. D. Mattia, F. Babiloni, A. Romigi et al., “Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer's disease: a correlative study,” Clinical Neurophysiology, vol. 114, no. 7, pp. 1210–1216, 2003. View at Publisher · View at Google Scholar · View at Scopus
65. L. Cavallin, R. Danielsson, A. R. Öksengard et al., “Can dynamic susceptibility contrast magnetic resonance imaging replace single-photon emission computed tomography in the diagnosis of patients with Alzheimer's disease? A pilot study,” Acta Radiologica, vol. 47, no. 9, pp. 977–985, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. B. F. Kjølby, L. Østergaard, and V. G. Kiselev, “Theoretical model of intravascular paramagnetic tracers effect on tissue relaxation,” Magnetic Resonance in Medicine, vol. 56, no. 1, pp. 187–197, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
67. C. S. Landis, X. Li, F. W. Telang et al., “Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange,” Magnetic Resonance in Medicine, vol. 44, no. 4, pp. 563–574, 2000. View at Publisher · View at Google Scholar · View at Scopus
68. C. Schwarzbauer, S. P. Morrissey, R. Deichmann, et al., “Quantitative magnetic resonance imaging of capillary water permeability and regional blood volume with an intravascular MR contrast agent,” Magnetic Resonance in Medicine, vol. 37, no. 5, pp. 769–777, 1997.
69. W. D. Rooney, T. E. Yankeelov, P. K. Coyle, et al., “Regional blood volumes and intravascular water lifetimes in human brain,” in Proceedings of the International Society for Magnetic Resonance in Medicine, vol. 11, p. 2188.
70. T. H. Jochimsen, R. D. Newbould, S. T. Skare et al., “Identifying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high-resolution multi-echo parallel EPI,” NMR in Biomedicine, vol. 20, no. 4, pp. 429–438, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
71. P. Caravan, J. J. Ellison, T. J. McMurry, and R. B. Lauffer, “Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications,” Chemical Reviews, vol. 99, no. 9, pp. 2293–2352, 1999. View at Publisher · View at Google Scholar · View at Scopus
72. P. S. Tofts and A. G. Kermode, “Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts,” Magnetic Resonance in Medicine, vol. 17, no. 2, pp. 357–367, 1991. View at Scopus
73. K. A. Broom, D. C. Anthony, A. M. Blamire et al., “MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 2, pp. 204–216, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
74. T. E. Yankeelov, W. D. Rooney, W. Huang et al., “Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology,” NMR in Biomedicine, vol. 18, no. 3, pp. 173–185, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
75. J. H. Lee, D. C. Medina, X. Li, et al., “Deuterium quenching of ¹H₂O relaxation in the living rat brain,” Proceedings of the International Society for Magnetic Resonance in Medicine, vol. 9, p. 529, 2001.
76. X. Li, W. D. Rooney, and C. S. Springer, “A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents,” Magnetic Resonance in Medicine, vol. 54, no. 6, pp. 1351–1359, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
77. P. Gowland and V. Stevenson, “T₁: the longitudinal relaxation time,” in Quantitative MRI of the Brain, P. S. Tofts, Ed., pp. 111–141, John Wiley & Sons, West Sussex, UK, 2003.
78. V. C. Anderson, D. P. Lenar, J. F. Quinn, J. A. Kaye, X. Li, and W. D. Rooney, “Quantitative characterization of blood brain barrier permeability in early AD: a pilot 7T DCE-MRI study,” in Proceedings of the International Conference on Alzheimer's Disease, Honolulu, Hawaii, USA, July 2010.
79. H. B. W. Larsson, M. Stubgaard, J. L. Frederiksen, M. Jensen, O. Henriksen, and O. B. Paulson, “Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors,” Magnetic Resonance in Medicine, vol. 16, no. 1, pp. 117–131, 1990.
80. P. S. Tofts, G. Brix, D. L. Buckley et al., “Estimating kinetic parameters from dynamic contrast-enhanced T- weighted MRI of a diffusable tracer: standardized quantities and symbols,” Journal of Magnetic Resonance Imaging, vol. 10, no. 3, pp. 223–232, 1999. View at Publisher · View at Google Scholar
81. H. Wang, E. J. Golob, and M. Y. Su, “Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls,” Journal of Magnetic Resonance Imaging, vol. 24, no. 3, pp. 695–700, 2006. View at Publisher · View at Google Scholar · View at PubMed
82. J. M. Starr, A. J. Farrall, P. Armitage, B. McGurn, and J. Wardlaw, “Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study,” Psychiatry Research, vol. 171, no. 3, pp. 232–241, 2009. View at Publisher · View at Google Scholar · View at PubMed
83. W. D. Rooney, T. E. Yankeelov, P. K. Coyle, F. W. Telang, and C. S. Springer, “Regional blood volumes and intravascular water lifetimes in human brain,” Proceedings of the International Society for Magnetic Resonance in Medicine, vol. 11, p. 2188, 2003.
84. G. C. Newman, E. Delucia-Deranja, A. Tudorica, F. E. Hospod, and C. S. Patlak, “Cerebral blood volume measurements by $T_{\ast }^2$-weighted MRI and contrast infusion,” Magnetic Resonance in Medicine, vol. 50, no. 4, pp. 844–855, 2003. View at Publisher · View at Google Scholar · View at PubMed
85. C. S. Landis, X. Li, F. W. Telang et al., “Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo,” Magnetic Resonance in Medicine, vol. 42, no. 3, pp. 467–478, 1999. View at Publisher · View at Google Scholar